These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 9153458)

  • 1. Lamotrigine trial in idiopathic parkinsonism: a double-blind, placebo-controlled, crossover study.
    Shinotoh H; Vingerhoets FJ; Lee CS; Uitti RJ; Schulzer M; Calne DB; Tsui J
    Neurology; 1997 May; 48(5):1282-5. PubMed ID: 9153458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Double-blind, placebo-controlled, crossover study of lamotrigine in treatment-resistant generalised epilepsy.
    Beran RG; Berkovic SF; Dunagan FM; Vajda FJ; Danta G; Black AB; Mackenzie R
    Epilepsia; 1998 Dec; 39(12):1329-33. PubMed ID: 9860069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The efficacy of lamotrigine in children and adolescents with refractory generalized epilepsy: a randomized, double-blind, crossover study.
    Eriksson AS; Nergårdh A; Hoppu K
    Epilepsia; 1998 May; 39(5):495-501. PubMed ID: 9596201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of orally dissolving carbidopa/levodopa (Parcopa) to conventional oral carbidopa/levodopa: A single-dose, double-blind, double-dummy, placebo-controlled, crossover trial.
    Ondo WG; Shinawi L; Moore S
    Mov Disord; 2010 Dec; 25(16):2724-7. PubMed ID: 20925074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lamotrigine therapy for partial seizures: a multicenter, placebo-controlled, double-blind, cross-over trial.
    Messenheimer J; Ramsay RE; Willmore LJ; Leroy RF; Zielinski JJ; Mattson R; Pellock JM; Valakas AM; Womble G; Risner M
    Epilepsia; 1994; 35(1):113-21. PubMed ID: 8112232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lamotrigine high-dose tolerability and safety in patients with epilepsy: a double-blind, placebo-controlled, eleven-week study.
    Matsuo F; Gay P; Madsen J; Tolman KG; Rollins DE; Risner ME; Lai AA
    Epilepsia; 1996 Sep; 37(9):857-62. PubMed ID: 8814098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lamictal (lamotrigine) monotherapy for typical absence seizures in children.
    Frank LM; Enlow T; Holmes GL; Manasco P; Concannon S; Chen C; Womble G; Casale EJ
    Epilepsia; 1999 Jul; 40(7):973-9. PubMed ID: 10403222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized double-blind parallel-group study comparing cognitive effects of a low-dose lamotrigine with valproate and placebo in healthy volunteers.
    Aldenkamp AP; Arends J; Bootsma HP; Diepman L; Hulsman J; Lambrechts D; Leenen L; Majoie M; Schellekens A; de Vocht J
    Epilepsia; 2002 Jan; 43(1):19-26. PubMed ID: 11879382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sinemet CR in Parkinson's disease.
    Pfeiffer RF; Wilken KE; Glaeske CS; Hofman R
    Nebr Med J; 1991 Jan; 76(1):8-10. PubMed ID: 1997878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A placebo-controlled study of lamotrigine and gabapentin monotherapy in refractory mood disorders.
    Frye MA; Ketter TA; Kimbrell TA; Dunn RT; Speer AM; Osuch EA; Luckenbaugh DA; Cora-Ocatelli G; Leverich GS; Post RM
    J Clin Psychopharmacol; 2000 Dec; 20(6):607-14. PubMed ID: 11106131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Controlled trial of lamotrigine (Lamictal) for treatment-resistant partial seizures.
    Boas J; Dam M; Friis ML; Kristensen O; Pedersen B; Gallagher J
    Acta Neurol Scand; 1996 Oct; 94(4):247-52. PubMed ID: 8937535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concurrent administration of donepezil HCl and levodopa/carbidopa in patients with Parkinson's disease: assessment of pharmacokinetic changes and safety following multiple oral doses.
    Okereke CS; Kirby L; Kumar D; Cullen EI; Pratt RD; Hahne WA
    Br J Clin Pharmacol; 2004 Nov; 58 Suppl 1(Suppl 1):41-9. PubMed ID: 15496222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human safety of lamotrigine.
    Betts T; Goodwin G; Withers RM; Yuen AW
    Epilepsia; 1991; 32 Suppl 2():S17-21. PubMed ID: 1837776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of lamotrigine on epileptiform discharges in young patients with drug-resistant epilepsy.
    Eriksson AS; Knutsson E; Nergårdh A
    Epilepsia; 2001 Feb; 42(2):230-6. PubMed ID: 11240595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levodopa and the progression of Parkinson's disease.
    Fahn S; Oakes D; Shoulson I; Kieburtz K; Rudolph A; Lang A; Olanow CW; Tanner C; Marek K;
    N Engl J Med; 2004 Dec; 351(24):2498-508. PubMed ID: 15590952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AFQ056 in Parkinson patients with levodopa-induced dyskinesia: 13-week, randomized, dose-finding study.
    Stocchi F; Rascol O; Destee A; Hattori N; Hauser RA; Lang AE; Poewe W; Stacy M; Tolosa E; Gao H; Nagel J; Merschhemke M; Graf A; Kenney C; Trenkwalder C
    Mov Disord; 2013 Nov; 28(13):1838-46. PubMed ID: 23853029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-dose lamotrigine augmentation therapy improves residual symptoms in treatment-resistant schizophrenia: a report of five cases.
    Ohnuma T; Takebayashi Y; Higashiyama R; Shibata N; Arai H
    Asia Pac Psychiatry; 2013 Dec; 5(4):336-43. PubMed ID: 24591092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of IPX066 with carbidopa-levodopa plus entacapone in advanced PD patients.
    Stocchi F; Hsu A; Khanna S; Ellenbogen A; Mahler A; Liang G; Dillmann U; Rubens R; Kell S; Gupta S
    Parkinsonism Relat Disord; 2014 Dec; 20(12):1335-40. PubMed ID: 25306200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy, safety, and tolerability of brivaracetam with concomitant lamotrigine or concomitant topiramate in pooled Phase III randomized, double-blind trials: A post-hoc analysis.
    Benbadis S; Klein P; Schiemann J; Diaz A; Elmoufti S; Whitesides J
    Epilepsy Behav; 2018 Mar; 80():129-134. PubMed ID: 29414542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lamotrigine in Parkinson's disease--a double blind study.
    Zipp F; Bürklin F; Stecker K; Baas H; Fischer PA
    J Neural Transm Park Dis Dement Sect; 1995; 10(2-3):199-206. PubMed ID: 9620063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.